WaferGen Turns First Quarterly Profit on SmartChip Early-Access Sales

On the heels of the full commercial launch of its SmartChip real-time PCR system earlier this month, WaferGen said that its revenues for the second quarter of 2010 grew by more than 500 percent year over year and nearly 10 percent sequentially due to early-access sales of the platform.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.